Get started
Author

Megan Lynn Hames Pollack

Observed names: M.H. Pollack, Megan H. Pollack, Megan Pollack, Pollack, Megan
ORCID: 0000-0001-8632-7984
Observed ORCID: 0000-0001-8632-7984
OpenAlex ID: A5035110956
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
2017 · M.H. Pollack, A. Betof, et al. · Annals of Oncology · 393
Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
2016 · Bridgette A. Kanz, Megan H. Pollack, et al. · Journal for ImmunoTherapy of Cancer · 75
PDF
Effect of Concomitant pH-Elevating Medications with Pazopanib on Progression-Free Survival and Overall Survival in Patients with Metastatic Renal Cell Carcinoma
2018 · Renee K. McAlister, Jonathan Aston, et al. · The Oncologist · 34
Emerging targeted therapies for melanoma
2016 · Douglas B. Johnson, Megan H. Pollack, et al. · Expert Opinion on Emerging Drugs · 26
Transforming approaches to treating TRK fusion cancer: historical comparison of larotrectinib and histology-specific therapies
2020 · Megan Pollack, Karen Keating, et al. · Current Medical Research and Opinion · 12
PDF
Safety of resuming anti-PD-1 (aPD1) in patients (pts) with immune-related adverse events (irAEs) during combined anti-CTLA-4 (aCTLA4) and aPD1 in metastatic melanoma (MM).
2017 · Megan Pollack, Allison Shayna Betof, et al. · Journal of Clinical Oncology · 1
Sequenced treatment after regorafenib and survival in metastatic colorectal cancer: a qualitative clinical review
2022 · Svetlana Babajanyan, Megan Pollack, et al. · Colorectal Cancer
Healthcare Costs in Elderly Patients with Acute Myeloid Leukemia (AML) in Routine Clinical Care in the United States (US)
2017 · Jill A. Bell, Aaron Galaznik, et al. · Blood
Prostate Cancer: Case-Based Learning
2017 · Megan Pollack · The American Pharmacists Association eBooks
Prostate Cancer: Faculty Materials
2017 · Megan Pollack · The American Pharmacists Association eBooks
Prostate Cancer
2017 · Megan Pollack · The American Pharmacists Association eBooks
Cyclooxygenase inhibition and response to anti-PD1/L1 in advanced melanoma.
2016 · Romany Anne Nilanthi Johnpulle, Megan Lynn Hames Pollack, et al. · Journal of Clinical Oncology
Anti-PD-1 in patients with advanced malignancies and baseline organ dysfunction.
2016 · Bridgette A Kanz, Megan Lynn Hames Pollack, et al. · Journal of Clinical Oncology
Talimogene laherparepvec in advanced melanoma
2016 · Megan H. Pollack, Jonathan Aston, et al. · Expert Opinion on Orphan Drugs
Works count: 15
Citation count: 541
H-index: 5
I10-index: 5
Year
Topic
Type